Two buys on the right track for growth

Article Excerpt

Long-time readers know that we keep you informed of important news about the stocks we cover. That means highlighting developments or strategies that promise to brighten your prospects. Here are two buys that stand out this month: THERMO FISHER SCIENTIFIC INC. $544.66, is a buy. The company (New York symbol TMO; TSINetwork Rating: Average) (www.thermofisher.com; Shares outstanding: 393.4 million; Market cap: $218.9 billion; Dividend yield: 0.2%) has signed a deal to provide sterile filling and finished product preparation services for Moderna’s COVID-19 vaccine. That’s the process of filling vials with vaccine and finishing the process of packaging the medicine for distribution. Many vaccine manufacturers use third parties to fill and finish their vaccines. The processing of Moderna’s messenger RNA (mRNA) vaccine will be done at a Thermo Fisher plant in North Carolina. Meanwhile, Moderna already has a standing relationship with Thermo Fisher, which has supplied the drugmaker with raw materials for its COVID-19 vaccine. Notably, at the same time, Thermo Fisher is already working…